Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (TCTR20260801003) titled 'Prevalence and risk factors for antimalarial drugs induced maculopathy in Phra Nakhon Si Ayutthaya Hospital' on Aug. 1.
Study Type: Observational
Primary Sponsor: NA
Condition:
antimalarial drugs induced maculopathy in rheumatic patients
antimalarial, chloroquine, hydroxychloroquine, maculopathy
antimalarial, chloroquine, hydroxychloroquine, maculopathy
Intervention:
patients diagnosed with antimalarial maculopathy,patients with no evidence of antimalarial-induced retinopathy
Prevention,Prevention
Recruitment Status: Not Recruiting
Date of First Enrollment: 01/10/2025
Target Sample Size: 176
Countries ...